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Background: Uncomplicated biliary colic presents a signiﬁcant health and ﬁnancial burden to hospitals
and primary care services alike. There is little guidance on the correct analgesia to use on an outpatient
basis. This study aimed to evaluate the effectiveness of oral analgesics on biliary colic pain and to explore
the prescribing habits of community doctors.
Methods: Consecutive patients with ultrasound proven symptomatic gallstones completed a question-
naire recording demographics and symptomatology. Pain was assessed using a visual analogue scale
(VAS) based on the Biliary Symptom Score (BSS) to evaluate the effectiveness of various analgesic agents.
Local General Practitioners were also surveyed to establish prescribing practices.
Results: Co-Codamol had the highest mean effectiveness VAS score (6.5/10). Patients with increased BMI,
short symptom duration and a BSS >70 were most likely to suffer from severe pain. Patients in a sub-
group with severe pain were most likely to have their pain reduced by NSAID analgesia compared to no
NSAID (OR 2.20, p ¼ 0.027). This effect remained signiﬁcant upon multivariable regression (OR 2.52,
p ¼ 0.018) in a model containing age and NSAIDs. There was wide variation in the prescribing practice of
GPs and hospital doctors.
Conclusions: The range of drugs prescribed for biliary colic is extensive with little evidence base. In this
study NSAIDs were the most effective analgesia for patients with severe pain. In the absence of con-
traindications to their use, physician education or guidance emphasizing the beneﬁts of NSAIDs may
potentially reduce symptomatic hospital presentation and admissions for biliary colic.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Biliary colic (BC) is the term used for gallbladder (GB) pain
experienced by patients without overt infection around the gall-
bladder. The pain is located in the epigastrium or right upper
quadrant of the abdomen and is typically colicky in nature due to
muscular spasm of the GB wall secondary to outﬂow tract
obstruction.1 BC affects 1e4% of the adult population known to
suffer with cholelithiasis (gallstones) and is the most common
presenting symptom.2presented at the Association
l Surgical Congress 2011, Liv-
, Imperial College London, St
Paddington, London W2 1NY,
4 (0) 207 886 6950.
n).
ciates Ltd. Published by Elsevier LtIn the United Kingdom (UK) episodes of BC are usually managed
with oral analgesia at home and settle spontaneously. However,
referral or self-presentation to hospital is often required if there is
diagnostic uncertainty or severe pain uncontrolled by available
analgesia. When a patient presents with biliary colic the most
important immediate step is adequate symptom control including
appropriate analgesia. There is good evidence for administration of
NSAID analgesia for patients presenting to the Emergency
Department with acute biliary colic.2,3 It is less clear what analgesia
these patients should be prescribed for outpatient management of
their pain.
Where patient preference and general health permit surgery,
the gold standard treatment for biliary colic and gallstones is
laparoscopic cholecystectomy (LC). In the UK the timing of LC varies
according to patient choice, waiting list length and local hospital
policy. Current practice is divided between centres providing ‘hot’
gallbladder services involving LC during the index admission and
those who schedule an elective interval LC. Both clinical and eco-
nomic aspects of these approaches have been examined previouslyd. All rights reserved.
M.J. Johnston et al. / International Journal of Surgery 12 (2014) 169e176170
ORIGINAL RESEARCHand remain under consideration.4e7 Currently, there is a lack of
clear guidelines recommending one option over the other. Thus
many patients are discharged to manage symptomatic disease in
the community while awaiting interval surgery or in preference to
surgery. This results in a signiﬁcant number of subsequent hospital
admissions for patients with recurrent biliary colic, unable to
control their pain with oral analgesia. These admissions present an
additional healthcare burden; in the National Health Service (NHS)
there were 105,910 hospital admissions for cholelithiasis in 2010e
2011.8
There is a paucity of guidance in the published literature
regarding the relative efﬁcacy of analgesic regimes patients receive
on discharge with the existing literature largely relating to inpa-
tient or emergency department treatment.9,10 Consequently, pa-
tients who present to their community General Practitioner (GP)
rather than a hospital are given analgesia according to anecdotal
factors such as personal preference or previous experience rather
than evidence based practice.
This study investigated the relative patient-reported effective-
ness of different analgesia regimes for outpatient management of
BC and compared these to current community physician (General
Practitioner) and hospital doctor prescribing practice.2. Methods
2.1. Patients and setting
University Hospital of Coventry & Warwickshire is a large
teaching hospital and tertiary referral centre offering a full range of
general surgery services. Over an 8-month period, consecutive
patients booked for laparoscopic cholecystectomy were included in
the study and ﬁlled out a questionnaire during their pre-operative
clinic appointment. Each patient had the presence of gallstones
conﬁrmed by ultrasonography. This study was undertaken as part
of an audit of service in the general surgery unit. Clinical audit
approval was granted by the hospital’s Quality & Effectiveness
Department.Table 1
A summary of basic patient demographics.
Male Female Total
n total 48 (24%) 155 (76%) 203
n 18e30 years 2 (6%) 33 (94%) 35 (17%)
n 31e50 years 14 (20%) 57 (80%) 71 (35%)
n 50 þ years 31 (32%) 66 (68%) 97 (48%)
Mean BMI 28.16 28.96 28.56
On pre-existing analgesia 9 (28%) 23 (72%) 32 (16%)2.2. Patient questionnaire
The authors formulated a questionnaire based on the informa-
tion required to calculate the Biliary Symptom Score (BSS).11 Several
iterations of this were trialed prior to a ﬁnal version. Repeated
practice meetings were held to ensure a consistent approach to
data collection by the researchers. The questionnaire recorded in-
formation regarding both prescribed and over the counter medi-
cations and did not discriminate between them. Patients were
asked to rate, on a visual analogue scale (VAS),12 the severity of
their pain with 0 rating as ‘no pain’ and 10 as ‘severe pain’. VAS
were also used to assess the subjective effect of the analgesic at
reducing pain with 0 rating as ‘no effect’ and 10 as ‘no pain’.13 The
questionnaire was non-mandatory and completion was taken as
consent to participate. The questionnaire can be seen in Appendix
1.
In addition to the patient questionnaire general practitioners
(GPs) from the local area were surveyed. All participants were
asked to return an answer to each of the questions outlined below
on a private digital keypad during an HPB surgery teaching session:
1. “Your patient has gallstones, what do you prescribe for future
biliary colic attacks?”
2. “The patient returns asking for stronger analgesia, now what do
you prescribe?”The options given to the GPs were “Nothing, Buscopan, Codeine,
NSAID, Pethidine tablets, Oramorph, Something else or Don’t
know.” Answers were returned using digital keypads ensuring
privacy.2.3. Inclusion and exclusion criteria
Patients included were adults with a diagnosis of biliary colic
undergoing elective laparoscopic cholecystectomy following ul-
trasound conﬁrmation of gallstones within their gallbladder. Pa-
tients were excluded from the study if they were unable to
remember the dosages of analgesia they were taking and this in-
formation could not be retrieved from the electronic discharge
summary. Any medication that could not be administered orally
was excluded from the study.2.4. Data analysis
A previously reported Biliary Symptom Score11 was calculated
for patients based on their questionnaire responses. Patient char-
acteristics were compared using the Chi-squared test. Patients were
divided into subgroups according to the severity of their pain on
presentation (a VAS score of >7 was considered to be severe pain).
A signiﬁcant reduction in pain was deﬁned as a reduction of 50%
of the post-analgesia VAS compared to the presenting VAS.
Univariate and multivariate logistic binary regression models
were built to determine predictors of signiﬁcant pain reduction. An
odds ratio (OR) and corresponding 95% conﬁdence interval (CI)
whichwere greater than 1.0 indicate an increased association of the
predictor variable (e.g. analgesic use) with the outcome (signiﬁcant
pain reduction), indicating a useful outcome. Variables which car-
ried a signiﬁcance of p< 0.1 at univariable level were entered into a
multivariable model, and were selected using a forward stepwise
process and if their p-value remained <0.05.
Data were collected and entered into Microsoft Excel 2011
(Microsoft Corporation, Redmond, USA) for descriptive analysis.
Data were analysed using SPSS 18.0 (SPSS Inc, Chicago, Illinois).
Financial conversions from £GBP to $USD and VEuro are based on
prevailing market rates on 22nd July 2013 using the UK Forex ex-
change rate, rounded to the nearest whole unit of currency.3. Results
3.1. Demographics
A total of 210 consecutive patients were asked to complete the
questionnaire, 7 patients were unable to remember the name or
dose of analgesia they were taking and were therefore excluded
leaving 203 patients in the study. Of these 155 (76%) were female
and 48 (24%) were male. Almost half (n ¼ 97 patients, [48%]) of the
patients were >50-years-old with 71 (35%) being 30e50-years-old
and 35 (17%) being 18e30-years-old (see Table 1). Ethnicity of pa-
tients was recorded with 171 (84%) classifying themselves as white
Fig. 1. A bar chart showing the 1st choice of analgesic agent for monotherapy patients.
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The mean BMI was 28.8 (18.5e46.9).
3.2. Analgesic choice
93 patients (46%) were supplied with Paracetamol for ﬁrst-line
pain relief with a further 25 patients using it as a second-line
analgesic. The second most commonly used agent was Co-
Codamol 30/500, which was used ﬁrst-line in 41 (20%) patients
and second-line in 12 patients. NSAID analgesia was used ﬁrst-line
in only 10% of patients. Buscopan was commonly used as a third-
line therapy (see Fig. 1). The preferred mode of analgesia was
monotherapy with 181 patients (89%) opting for this over combi-
nation therapies.
3.3. Perceptions of pain by different groups
Overall, 147 patients (72%) had experienced BC symptoms for
longer than six-months. Patients under 30-years of age subjectively
reported the most severe pain with an average VAS of 9/10. Those
patients aged 30e50 experienced less severe pain (8.6/10). Patients
over 50 years of age experienced the least severe pain with a mean
score of 8.3/10; there were no signiﬁcant differences between these
groups in terms of pain VAS scoring. Female patients rated their
pain as more severe than male patients with a mean VAS score of
8.6/10 compared to 8.1/10. The majority who were taking regular
analgesia for a pre-existing co-morbidity had lower limb osteoar-
thritis (34 patients [17%]).
3.4. Comparison of reported-effectiveness
Co-Codamol tablets (30 mg/500 mg) had the highest post-
analgesia mean VAS score of 6.5/10 followed by tramadol. BothFig. 2. A bar chart showing the meNSAIDs (Diclofenac and Ibuprofen) had lower mean VAS scores
than opiate medications with Paracetamol having the lowest score
of 3.85/10 (see Fig. 2). There were no signiﬁcant differences be-
tween the post-analgesia mean VAS scoring for different agents.
There were 166 patients with severe pain (a VAS score >7).
These patients were most likely to have an increased BMI, a shorter
duration of symptoms and a Biliary Symptom Score >70 (see
Table 2). Those with a VAS score >7 were most likely to be taking
either NSAID or opioid analgesia in their analgesia regime, not
necessarily as a 1st choice (see Table 2). Patients with severe pain
were most likely to have their pain reduced by 50% or more when
treated with NSAID analgesia compared to no NSAID (OR 2.20,
p ¼ 0.027). This effect remained signiﬁcant upon multivariable
regression (OR 2.52, p ¼ 0.018) in a model containing age and
NSAIDs (see Table 3). The effect seen with opioid medications was
not signiﬁcant (OR 0.87, p ¼ 0.680).4. General practitioner prescribing practice
A total of 124 local GPs participated in the survey. There was no
clear pattern or agreement between GPs when asked about their
initial prescription for a BC patient. A quarter opted for Buscopan
(26%), Codeine (23%) or an NSAID (25%). The other quarter of par-
ticipants opted for stronger analgesia with 14% choosing Pethidine
tablets and 8% choosing Oramorph. There were 10 abstentions (a
response rate of 92%).
If the patient returned for stronger analgesia 23% of GPs stated
they would prescribe Oramorph, 17% an NSAID, 15% Pethidine, 14%
Codeine and 11% Buscopan. However, 18% of GPs stated they would
choose something else entirely or that they wouldn’t knowwhat to
prescribe and 32 GPs abstained (a response rate of 74%), indicating
a substantial degree of variation in their practice. These results are
available in Table 4 and Fig. 3.an post analgesia VAS scores.
Table 2
Analysis of factors associated with severe pain (represented by VAS > 7).
Factor Sub-group Total VAS  7 VAS > 7 p Value
n (%) n (%) n (%)
Age (years) 18e30 35 (17.2%) 3 (8.1%) 32 (19.3%)
31e50 71 (35.0%) 12 (32.4%) 59 (35.5%)
50þ 97 (47.8%) 22 (59.5%) 75 (45.2% 0.168
Gender Male 48 (23.6%) 12 (32.4%) 36 (21.7%)
Female 155 (76.4%) 25 (67.6%) 130 (78.3%) 0.164
Ethnicity White
British
167 (82.3%) 28 (75.7%) 139 (83.7%)
Asian 24 (11.8%) 7 (18.9%) 17 (10.2%)
Afro-
Caribbean
12 (5.9%) 2 (5.4%) 10 (6%) 0.335
Body Mass
Index
BMI  25 46 (22.7%) 13 (35.1%) 33 (19.9%)
BMI > 25 157 (77.3%) 24 (64.9%) 133 (80.1%) 0.045
Symptom
duration
(months)
1e3 24 (11.8%) 1 (2.7%) 23 (13.9%)
3e6 36 (17.7%) 4 (10.8%) 32 (19.3%)
>6 143 (70.4%) 32 (86.5%) 111 (66.9%) 0.048
Chronic illness Not present 170 (83.7%) 30 (81.1%) 140 (84.3%)
Present 33 (16.3%) 7 (18.9%) 26 (15.7%) 0.627
Biliary symptom
score
70 111 (54.7%) 26 (70.3%) 85 (51.2%)
>70 92 (45.3%) 11 (29.7%) 81 (48.8%) 0.035
Analgesia taken
(Either NSAID
or Opioid)
No NSAID 141 (69.5%) 20 (54.1%) 121 (72.9%)
Taking
NSAID
62 (30.5%) 17 (45.9%) 45 (27.1%) 0.024
No opioid 79 (38.9%) 24 (64.9%) 55 (33.1%)
Taking
opioid
124 (61.1%) 13 (35.1%) 111 (66.9%) <0.001
Table 4
Initial analgesia and stronger analgesia prescribing choices from community GPs.
Drug Initial choice (n ¼ 124) Stronger choice (n ¼ 124)
Nothing 1 2
Buscopan 24 11
Codeine 22 3
NSAID 24 4
Pethidine tablets 12 13
Oramorph 8 20
Something else 3 15
Don’t know 20 24
M.J. Johnston et al. / International Journal of Surgery 12 (2014) 169e176172
ORIGINAL RESEARCH5. Discussion
The main ﬁnding of this study was that Co-Codamol is the most
effective agent for biliary colic patients. Overall the analgesic agents
prescribed for biliary colic have relatively poor effectiveness with a
highest post-analgesia VAS of 6.48 for Co-Codamol tablets. The
secondary ﬁnding of this study is that NSAID analgesia is the most
effective agent for a subset of patients suffering from severe pain.
These patients tended to be obese with a high biliary symptom
score and a shorter duration of symptoms. In addition to this, it was
identiﬁed that patients prefer analgesic monotherapy to combi-
nation therapy. There was no consensus in the GP group regarding
appropriate prescribing for biliary colic, they tended to prescribe
either an NSAID or weak opioid initially which is consistent with
the patient questionnaire results. However, GPs advanced up the
pain ladder more swiftly than their hospital colleagues by way of
prescribing Oramorph or Pethidine for a greater number of their
patients than hospital doctors. The broad spread of analgesic agentsTable 3
Univariate and multivariate regression for a 50% reduction in VAS score.
Factor Sub-group Univariable
Odds ratio 95% Conﬁdence
Age (years) 18e30 Ref
31e50 3.325 1.237e8.935
50þ 2.946 1.132e7.668
Gender Male Ref
Female 0.997 0.470e2.115
Ethnicity White British Ref
Asian 1.033 0.363e2.936
Afro-Caribbean 0.332 0.068e1.622
Body Mass Index Value > 25 0.821 0.380e1.774
Symptom duration (months) 1e3 Ref
3e6 0.363 0.118e1.111
>6 0.465 0.183e1.183
Chronic Illness 1.993 0.842e4.718
Any NSAID 2.202 1.094e4.432
Any opioid 0.868 0.442e1.704used for biliary colic by GPs and hospital doctors is likely due to a
lack of evidence-based guidelines, leading to individualized pre-
scribing habits and preventable variation in practice. In addition,
the higher number of GP abstentions to the second question in-
dicates a degree of uncertainty regarding the appropriate analgesia
for refractory BC.
Literature regarding analgesia in biliary colic is, for the most
part, restricted to recommendations on treatment used in the
emergency department14 or administered parenterally.15 Selected
literature investigating the role of analgesia in acute biliary colic
attacks performed during the last 25 years is displayed in Table 5.
It is clear that the majority of studies recommend NSAIDs
for treatment of acute biliary colic in the Emergency Depart-
ment; the best analgesia for outpatient management remains
unclear.
Additional signiﬁcance of this study lies in the fact that BC
presents a substantial ﬁnancial burden to health services. It is
estimated that uncomplicated BC admissions in English hospitals
cost the NHS £23,829,750 (approximately $36,535,808 or
V27,698,527) in 2010e2011 (assuming a 1-night inpatient stay).8,16
Our study suggests that a streamlining of the approach to outpa-
tient management of BC could help to reduce the number of hos-
pital admissions, leading to an associated cost saving.
Despite easy availability, NSAIDs were used less commonly than
we expected in this study. There are several possible reasons for
this. Codeine and other weak opioids commonly cause con-
stipation, an inconvenient side effect, but not life-threatening.
NSAIDs, especially in the younger population are relatively safe
but have some serious side effects including increased risk of
gastrointestinal haemorrhage and acute kidney injury.17e19 These
factors may persuade patients to avoid NSAIDs. It may have also
dissuaded doctors from prescribing NSAIDs more commonly,
especially to those at risk of side effects such as elderly or asthmaticMultivariable
intervals p Value Odds ratio 95% Conﬁdence intervals p Value
0.047 Ref 0.035
0.017 3.085 1.125e8.463 0.029
0.027 3.648 1.345e9.896 0.011
0.994
0.390
0.952
0.173
0.616
0.180
0.076
0.465
0.117
0.027 2.517 1.171e5.410 0.018
0.680
Fig. 3. A bar chart showing the initial and stronger analgesia choices of GPs.
Table 5
Summary of previous studies reporting comparative efﬁcacy of analgesic agents in biliary colic.
Author Year Study design Level of evidence Setting Conclusion
Basurto et al.10 2008 Systematic review
& meta-analysis
1þþ ED NSAIDs are the analgesia of choice for uncomplicated biliary colic and
prevent progression to cholecystitis
Kumar et al.15 2004 Randomized,
blinded study
2þ ED IM Diclofenac gives better pain relief than IM Hyoscine and prevents
progression to cholecystitis
Colli et al.9 2012 Meta-analysis 1þþ ED NSAIDs are ﬁrst choice treatment for biliary colic. Opioids have similar
efﬁcacy but more complications
Akriviadis et al.22 1997 RCT 1þ ED IM Diclofenac is a more effective painkiller than IM Saline and reduces
progression to cholecystitis
Goldman et al.23 1989 Randomized
double-blinded
study
2þ ED Diclofenac is the analgesia of choice in acute biliary colic and may
decrease progression to cholecystitis
Olsen et al.2 2008 Randomized
double-blinded
2þ ED Both Ketorolac and Butorphanol are reasonable choices for treating
acute biliary colic
Henderson et al.3 2002 Randomized trial 2þ ED Both Ketorolac and Meperidine are effective in treating acute biliary
colic
Schmieder et al.24 1993 Randomized single-
blinded
2þ ED Metamizole is a more effective painkiller in acute biliary colic than
Tramadol and Butylscopolamine
Level of evidence as per the SIGN grading system, developed by The Scottish Intercollegiate Guidelines Network.25
ED ¼ Emergency Department; IM ¼ Intra-muscular.
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biliary colic is gastritis/gastro-oesophageal reﬂux disease, a condi-
tion that can be exacerbated by NSAID use.
The severity of pain experienced by patients in this study is
worst in young females and decreases with increasing age andmale
sex. There may be several contributing factors to this such as
acceptance of pain in older age groups or those on pre-existing
medications (there were 32 [16%] in this study). However other
studies have found that gender and age cause no signiﬁcant dif-
ference in signiﬁcant VAS scores.20 This underlines the point that a
patient’s genotype and phenotype may both have a role to play in
both perception of and response to pain.
One of the strengths of this study is the large sample size of
patients limiting the effects of participant bias. The broad sample of
GPs also means that prescribing habits from a wide region were
captured, eliminating the potential for localized habits to affect the
survey results, which may make the ﬁndings more generalizable to
other areas of the UK.
There are limitations of this study; one of these is the subjec-
tivity of VAS. Given the inevitable heterogeneity of pain interpre-
tation in patients some inconsistency in this respect was
unavoidable. There will be a degree of participant recall bias
resulting from patients being asked to recall the severity of their
symptoms at an unspeciﬁed interval. This study only looks at those
patients who are scheduled for operative intervention, therefore
the extent to which these results can be extrapolated to patients
treated conservatively is unknown. Although cases are deﬁned on
the basis of having been listed for surgery following ultrasoundﬁndings consistent with gallstone aetiology, these patients have
not been followed through post-operatively so we cannot deﬁni-
tively say their symptomatology was secondary to gallstones. Rates
of post-cholecystectomy syndrome vary in the literature between
10 and 15% so this phenomenon could potentially be a cofounding
factor.21
Optimization of oral medication is important for biliary colic
patients and further research in this area is needed before the most
effective analgesia for outpatient management of biliary colic can
be established. It is clear from the results of this study that doctors
do not know what to prescribe their biliary colic patients. Future
work should concentrate on validating objective metrics to mea-
sure analgesia effectiveness in the setting of biliary colic, such as
morbidity and hospital admission rates.6. Conclusions
This study has shown the degree of variance and uncertainty in
outpatient prescribing for biliary colic. It remains important to
individualize medication to ensure that the beneﬁt of potentially
harmful drugs such as NSAIDs outweigh the risks to the patient. A
prospective randomized study exploring this issue is required
before clear guidance can be given to doctors on outpatient pre-
scribing for biliary colic.Funding
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